Literature DB >> 30838613

Lipids for Nucleic Acid Delivery: Cationic or Neutral Lipoplexes, Synthesis, and Particle Formation.

Michel Bessodes1,2,3,4, Helene Dhotel1,2,3,4, Nathalie Mignet5,6,7,8.   

Abstract

Lipidic vesicles have been extensively studied for their capacity to condensate and deliver nucleic acids to the cells. Many different amphiphilic lipidic structures have been proposed each of them bringing some advances in nonviral gene transfection. The ionic or neutral nature of the lipids induces tremendous differences in the behavior of the corresponding liposomes, from the complexation of nucleic acid to the delivery to the cell. An efficient delivery in vitro or in vivo also depends closely on the structure of the lipids and very often, efficient liposomes in vitro have been found useless for in vivo administration.We describe in this chapter the chemical synthesis of two different lipids, one cationic and the other essentially neutral, and the formulation to obtain liposomes and DNA-liposome complexes. The different ways and tricks for the formulation of the two different structures are especially highlighted.

Entities:  

Keywords:  Cationic lipid; DNA–lipid complex stabilization; Ethanolic injection; Lipid synthesis; Lipoplex characterization; Liposome formulation; Noncationic lipid

Mesh:

Substances:

Year:  2019        PMID: 30838613     DOI: 10.1007/978-1-4939-9092-4_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

2.  Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response.

Authors:  Hai Doan Do; Corinne Marie; Stéphanie Bessoles; Hélène Dhotel; Johanne Seguin; Benoit Larrat; Bich-Thuy Doan; Daniel Scherman; Virginie Escriou; Salima Hacein-Bey-Abina; Nathalie Mignet
Journal:  Explor Target Antitumor Ther       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.